PICTET ASSET MANAGEMENT SA - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
PICTET ASSET MANAGEMENT SA ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$42,597,932
+21.5%
1,044,579
+11.1%
0.05%
+15.9%
Q1 2023$35,052,286
+128376.7%
940,496
+20.3%
0.04%
+12.8%
Q4 2022$27,283
-99.9%
781,978
+2.1%
0.04%
-39.1%
Q3 2022$42,874,000
+30.3%
766,162
+20.5%
0.06%
+39.1%
Q2 2022$32,912,000
+23.6%
635,850
+73.5%
0.05%
+53.3%
Q1 2022$26,636,000
-46.6%
366,533
-13.1%
0.03%
-40.0%
Q4 2021$49,893,000
+45.7%
421,964
+65.3%
0.05%
+31.6%
Q3 2021$34,238,000255,2240.04%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders